101 unknown. 101 Phase 2, 20 Phase 3, 18 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 101 | Unknown 101 |
| Phase 3 | 20 | Unknown 20 |
| Phase 1 | 18 | Unknown 18 |
Follow Bone Diseases: new trials by email Literature Review of Bone Diseases trials Research Report on Bone Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis SCT650C - Axial Spondyloarthritis | Phase 2 | Unknown | Sinocelltech Ltd. | 168 | 2024-07-01 | 2024-01-09 |
| Vosoritide for Short Stature in Turner Syndrome Vosoritide - Turner Syndrome, Short Stature | Phase 2 | Unknown | Roopa Kanakatti Shankar, MBBS, MS | 20 | 2024-04-12 | 2024-06-24 |
| A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS) 608 Dose A, 608 Dose B, 608 Dose C - Ankylosing Spondylitis | Phase 2 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 250 | 2024-03-19 | 2024-10-23 |
| Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis HS-10374, HS-10374-matched placebo tablets, Tofacitinib 5Mg Tab,Oral - Psoriatic Arthritis | Phase 2 | Unknown | Hansoh BioMedical R&D Company | 160 | 2024-02-26 | 2024-07-18 |
| Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib Baricitinib 2mg, Tofacitinib 5 mg - Spondyloarthritis, Axial | Phase 2 | Unknown | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 184 | 2023-10-30 | 2023-12-21 |
| Radiographic Assessment of Bone Dimension Around Immediate Implants With FDBA and I-PRF vs FDBA Alone i-PRF and FDBA - Bone Density Increased | Phase 2 | Unknown | Krishnadevaraya College of Dental Sciences & Hospital | 20 | 2023-07-15 | 2024-07-30 |
| Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis 400 IU, 5000 IU, 10000 IU - Spondylitis, Tuberculosis | Phase 2 / Phase 3 | Unknown | Hasanuddin University | 37 | 2022-07-01 | 2022-05-17 |
| Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis JMT103, Denosumab, Placebo - Postmenopausal Osteoporosis | Phase 2 | Unknown | Shanghai JMT-Bio Inc. | 200 | 2022-04-21 | 2022-07-18 |
| Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors Doxorubicin, Cisplatin, Methotrexate, Doxorubicin, Cisplatin - Osteosarcoma, Neoplasms, Connective Tissue | Phase 2 / Phase 3 | Unknown | Blokhin's Russian Cancer Research Center | 50 | 2022-01-10 | 2024-04-01 |
| Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis Botulinum toxin type A, Isometric Yoga-like exercise, Placebo - Scoliosis Idiopathic, Scoliosis; Adolescence | Phase 2 | Unknown | Manhattan Physical Medicine and Rehabilitation, LLP | 42 | 2021-07-01 | 2023-10-19 |
| Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas Trabectedin - Soft Tissue Sarcoma, Bone Tumors | Phase 2 | Unknown | Grupo Espanol de Investigacion en Sarcomas | 85 | 2021-05-28 | 2023-03-27 |
| Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction EB-CMF - Mandible Tumor, Mandibular Injuries | Phase 1 / Phase 2 | Unknown | Epibone, Inc. | 6 | 2021-03-31 | 2022-05-27 |
| The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture Ozempic, Placebo - Osteopenia | Phase 1 / Phase 2 | Unknown | Morten Frost | 64 | 2021-03-24 | 2021-03-30 |
| Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD Autologous BM-MSC, Sham - Intervertebral Disc Degeneration, Chronic Low-back Pain | Phase 2 | Unknown | Fondazione Policlinico Universitario Campus Bio-Medico | 52 | 2021-03-22 | 2025-05-25 |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis | Phase 1 / Phase 2 | Unknown | All Natural Medicine Clinic, LLC | 2000 | 2021-03-01 | 2021-05-26 |
| Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion ART352-L - Degenerative Spondylolisthesis | Phase 1 / Phase 2 | Unknown | Ankasa Regenerative Therapeutics, Inc. | 12 | 2020-09-30 | 2020-10-12 |
| KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion TGplPTH1-34 in fibrin, Autologous Bone Graft - Degenerative Disc Disease, Spinal Fusion | Phase 2 | Unknown | Kuros Biosurgery AG | 50 | 2020-08-27 | 2023-08-09 |
| Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement Tofacitinib 5 MG Oral Tablet [Xeljanz], Placebo oral tablet - Psoriatic Arthritis, Spondylitis | Phase 2 | Unknown | Charite University, Berlin, Germany | 80 | 2020-08-04 | 2022-07-26 |
| Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients Mesenchymal Stem Cell - Osteoporosis | Phase 2 | Unknown | Ahmad Jabir Rahyussalim | 5 | 2020-08-01 | 2020-08-07 |
| Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations Infigratinib - Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Unknown | LianBio LLC | 80 | 2020-05-13 | 2022-06-27 |
Showing 20 of 101. Sign in to see all of them.
Osteoporosis (17) · Spondylitis, Ankylosing (13) · Bone Diseases, Metabolic (10) · Intervertebral Disc Degeneration (9) · Alveolar Bone Loss (6) · Osteoporosis, Postmenopausal (6) · Bone Neoplasms (5) · Low Back Pain (5) · Arthritis, Psoriatic (4) · Axial Spondyloarthritis (4) · Spondylarthritis (4) · Spondylolisthesis (4) · Dwarfism, Pituitary (3) · Intervertebral Disc Displacement (3) · Osteonecrosis (3)
Musculoskeletal Diseases (99) · Spinal Diseases (40) · Joint Diseases (25) · Metabolic Diseases (25) · Nutritional and Metabolic Diseases (25) · Arthritis (22) · Spondylitis (22) · Spondylarthropathies (21) · Spondylarthritis (19) · Pathological Conditions, Signs and Symptoms (18) · Ankylosis (15) · Bone Diseases, Metabolic (15) · Bone Diseases, Developmental (13) · Axial Spondyloarthritis (12)
Etanercept (5) · tofacitinib (4) · Adalimumab (3) · Alendronate (3) · Cholecalciferol (3) · Denosumab (3) · Human Growth Hormone (3) · Methotrexate (3) · Sulfasalazine (3) · Teriparatide (3) · Zoledronic Acid (3) · Calcium (2) · Growth Hormone (2) · Meloxicam (2) · Pamidronate (2)
Charite University, Berlin, Germany (10) · Ahmad Jabir Rahyussalim (3) · Shinshu University (3) · Tel-Aviv Sourasky Medical Center (3) · BioSurface Engineering Technologies, Inc (2) · Changchun GeneScience Pharmaceutical Co., Ltd. (2) · University of Aarhus (2) · All Natural Medicine Clinic, LLC (1) · Altus Pharmaceuticals (1) · Ankasa Regenerative Therapeutics, Inc. (1) · Assaf-Harofeh Medical Center (1) · Assistance Publique - Hôpitaux de Paris (1) · Azelon Pharmaceuticals (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Biomatlante (1)
United States (20) · China (15) · Germany (10) · France (4) · Indonesia (4) · Italy (4) · Denmark (3) · India (3) · Iran (3) · Japan (3) · Russia (3) · Taiwan (3) · United Kingdom (3) · Australia (2) · Bangladesh (2)
Joachim Sieper, Prof. (3) · Joachim Sieper, MD (2) · Joachim Sieper, Prof. Dr. (2) · AJ Gelderblom, Prof (1) · Abdalla Awidi (1) · Alex Mullen (1) · Amir Ali Hamidieh, MD (1) · Andi Alfian Zainuddin, MD. Ph.D (1) · Ann Wenzel, professor (1) · Anton Sculean, Prof. (1) · Antonio Casado (1) · Asadul Islam, MBBS (1) · Beniamin Bokhyan, PhD (1)
PMID 24476416, PMID 17077737, PMID 18576337, PMID 19830485, PMID 20061334, PMID 20193083, PMID 20461780, PMID 21138567, PMID 21425247, PMID 22289280, PMID 23321647, PMID 23625982, PMID 23686466, PMID 23786760, PMID 24716739, PMID 25028375, PMID 25140041, PMID 25315149, PMID 25568820, PMID 26021713, PMID 27108405, PMID 27206923, PMID 28590796, PMID 29788942, PMID 30355512, PMID 32484386, PMID 32524605, PMID 32678055, PMID 33306625, PMID 33717658, PMID 34717922, PMID 34785545, PMID 36410666, PMID 37269909, PMID 37338608, PMID 37449658, PMID 38737002, PMID 39762123, PMID 40200363, PMID 40686685, PMID 42254059, PMID 42337043
2019 (1), R01AR056651 (1), R21AI058756 (1)